Sanofi Pasteur, A Sanofi Company

This early-stage study is testing a new mRNA vaccine designed to help control mild acne. About 120 healthy adults aged 18-45 with mild facial acne will receive two shots of either the vaccine or a placebo. Researchers will track safety, side effects, and whether the vaccine reduc…

This study is testing a new mRNA vaccine designed to help control moderate to severe acne in adults aged 18 to 45. Researchers will give up to three injections at different dose levels to 260 participants to see how safe the vaccine is and if it reduces acne lesions. The goal is …

This study is creating a registry to monitor the safety of the MenQuadfi meningococcal vaccine when given to pregnant women. It will follow about 50 women who got the vaccine during pregnancy or just before, tracking their health and their baby's health for up to a year after bir…

This study aims to monitor the safety of the Dengvaxia dengue vaccine in pregnant women and their children. It will follow about 500 women in the US who received the vaccine while pregnant, tracking their health and their baby's health for up to one year after birth. The goal is …